FRIEDMAN MICHAEL R.
SEC insider (Form 3/4/5 filer). CIK 0001993243. Director at Galera Therapeutics, Inc. (GRTX). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in MALVERN, PA.
Companies FRIEDMAN MICHAEL R. has filed insider reports for
- Galera Therapeutics, Inc. (GRTX): Director
FRIEDMAN MICHAEL R.
CIK: 0001993243
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Galera Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 3, 2026GRTX
Galera Therapeutics, Inc.
DispositionIndirect41.6K shares- - May 15, 2026GRTX
Galera Therapeutics, Inc.
ConversionIndirect3M shares- - Apr 7, 2026GRTX
Galera Therapeutics, Inc.
ConversionIndirect5.3M shares- - Feb 24, 2025GRTX
Galera Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
96K shares- - Dec 30, 2024GRTX
Galera Therapeutics, Inc.
AwardIndirectSeries B Preferred Stock
8.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 | GRTX Galera Therapeutics, Inc. | Disposition | 41,631 | - | $0 | Indirect |
| May 15, 2026 | GRTX Galera Therapeutics, Inc. | Conversion | 2,989,399 | - | $0 | Indirect |
| Apr 7, 2026 | GRTX Galera Therapeutics, Inc. | Conversion | 5,336,870 | - | $0 | Indirect |
| Feb 24, 2025 | GRTX Galera Therapeutics, Inc. | Award Stock Option (Right to Buy) | 96,000 | - | - | Direct |
| Dec 30, 2024 | GRTX Galera Therapeutics, Inc. | Award Series B Preferred Stock | 8,326 | - | - | Indirect |
1-5 of 5 transactions